BioCentury
ARTICLE | Clinical News

Prevacid lansoprazole: Phase I started

February 15, 2010 8:00 AM UTC

Takeda began an open-label, U.S. Phase I trial in 160 healthy volunteers to evaluate several proton pump inhibitors (PPIs) in combination with 75 mg once-daily Plavix clopidogrel. PPIs in the trial w...